Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Velsera
Genomics and multi-omics informatics platform combining bioinformatics infrastructure with clinical genomics interpretation.
Velsera, headquartered in Boston, Massachusetts, was formed in 2022 and publicly announced in January 2023 through the combination of Seven Bridges, PierianDx and UgenTec, uniting research bioinformatics infrastructure with clinical genomics interpretation and diagnostics workflow software. Summa Equity backs the company, which operates under its own brand. Velsera does not publish a public security certification page, so request security and compliance documentation during evaluation.
- Headquarters
- Boston, United States
- Founded
- 2022
- Deployment options
- cloud
- Website
- https://velsera.com
- https://www.linkedin.com/company/velseraofficial
Categories
Vendor Scorecard
50% — Partial coverage. Coverage score — how completely Atlas documents Velsera across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, Academic / Research, Data Engineer / Architect, Drug Discovery, R&D Leadership
Solution Scope — Documented
Biomarker Discovery
Company Viability — Partially documented
Private equity, Founded 2022
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- How are the legacy Seven Bridges and PierianDx platforms being unified?
- What security and compliance documentation can be provided?
- Which workloads run in our environment versus Velsera-managed infrastructure?
- What is the roadmap for the combined platform over the next 12 months?